Literature DB >> 9729456

Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity.

K Wenzel-Seifert1, T W Lee, R Seifert, B K Kobilka.   

Abstract

The beta2-adrenoceptor (beta2AR) activates the G-protein Gsalpha to stimulate adenylate cyclase (AC). Fusion of the beta2AR C-terminus to the N-terminus of Gsalpha (producing beta2ARGsalpha) markedly increases the efficiency of receptor/G-protein coupling compared with the non-fused state. This increase in coupling efficiency can be attributed to the physical proximity of receptor and G-protein. To determine the optimal length for the tether between receptor and G-protein we constructed fusion proteins from which 26 [beta2AR(Delta26)Gsalpha] or 70 [beta2AR(Delta70)Gsalpha] residues of the beta2AR C-terminus had been deleted and compared the properties of these fusion proteins with the previously described beta2ARGsalpha. Compared with beta2ARGsalpha, basal and agonist-stimulated GTP hydrolysis was markedly decreased in beta2AR(Delta70)Gsalpha, whereas the effect of the deletion on binding of guanosine 5'-[gamma-thio]triphosphate (GTP[S]) was relatively small. Surprisingly, deletions did not alter the efficiency of coupling of the beta2AR to Gsalpha as assessed by GTP[S]-sensitive high-affinity agonist binding. Moreover, basal and ligand-regulated AC activities in membranes expressing beta2AR(Delta70)Gsalpha and beta2AR(Delta26)Gsalpha were higher than in membranes expressing beta2ARGsalpha. These findings suggest that restricting the mobility of Gsalpha relative to the beta2AR results in a decrease in G-protein inactivation by GTP hydrolysis and thereby enhanced activation of AC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729456      PMCID: PMC1219717          DOI: 10.1042/bj3340519

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Measurement of agonist-induced guanine nucleotide turnover by the G-protein Gi1alpha when constrained within an alpha2A-adrenoceptor-Gi1alpha fusion protein.

Authors:  A Wise; I C Carr; G Milligan
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Activation of a beta 2-adrenergic receptor/Gs alpha fusion protein elicits a desensitization-resistant cAMP signal capable of inhibiting proliferation of two cancer cell lines.

Authors:  B Bertin; R Jockers; A D Strosberg; S Marullo
Journal:  Receptors Channels       Date:  1997

3.  Direct or C5a-induced activation of heterotrimeric Gi2 proteins in human neutrophils is associated with interaction between formyl peptide receptors and the cytoskeleton.

Authors:  E Särndahl; G M Bokoch; F Boulay; O Stendahl; T Andersson
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

4.  Glycosylation, palmitoylation, and localization of the human D2S receptor in baculovirus-infected insect cells.

Authors:  S Grünewald; W Haase; H Reiländer; H Michel
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

5.  Receptor-induced translocation of activated guanine-nucleotide-binding protein alpha i subunits to the cytoskeleton in myeloid differentiated human leukemia (HL-60) cells.

Authors:  T Wieland; D Meyer zu Heringdorf; R A Schulze; S Kaldenberg-Stasch; K H Jakobs
Journal:  Eur J Biochem       Date:  1996-08-01

6.  Measurement of receptor-stimulated guanosine 5'-O-(gamma-thio)triphosphate binding by G proteins.

Authors:  T Weiland; K H Jakobs
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

7.  Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein.

Authors:  B Bertin; M Freissmuth; R Jockers; A D Strosberg; S Marullo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits.

Authors:  D M Berman; T M Wilkie; A G Gilman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

9.  Regulation of phospholipase C-beta1 by Gq and m1 muscarinic cholinergic receptor. Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation.

Authors:  G H Biddlecome; G Berstein; E M Ross
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

10.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes.

Authors:  U Gether; S Lin; B K Kobilka
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

View more
  5 in total

1.  The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.

Authors:  Kurt A Krobert; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expression.

Authors:  Michael A Hanson; Alexei Brooun; Kent A Baker; Veli-Pekka Jaakola; Chris Roth; Ellen Y T Chien; Alexander Alexandrov; Jeffrey Velasquez; Leila Davis; Mark Griffith; Kin Moy; Barbie K Ganser-Pornillos; Yuanzi Hua; Peter Kuhn; Sam Ellis; Mark Yeager; Raymond C Stevens
Journal:  Protein Expr Purif       Date:  2007-06-27       Impact factor: 1.650

3.  Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.

Authors:  Paola Rogliani; Maria Gabriella Matera; Francesco Facciolo; Clive Page; Mario Cazzola; Luigino Calzetta
Journal:  Br J Pharmacol       Date:  2020-01-29       Impact factor: 8.739

4.  In vivo assembly and large-scale purification of a GPCR - Gα fusion with Gβγ, and characterization of the active complex.

Authors:  Abhinav Kumar; Andreas Plückthun
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

5.  Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.

Authors:  Yang Han; Irina S Moreira; Eneko Urizar; Harel Weinstein; Jonathan A Javitch
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.